Streamlined Pathways
to Clinical Trials

Trials mark a critical turning point in drug development.

Clinical Expressway ensures you reach this milestone by bringing together Benuvia’s formulation, analytical, and regulatory expertise to remove obstacles and pave a direct route to clinical readiness. From producing clinical trial materials to meeting strict compliance standards, we handle the complexities so you can focus on advancing your science. With Clinical Expressway, your journey to the clinic is as efficient and stress-free as possible.

Streamline your path to clinical trials

Clinical Expressway capabilities eliminate delays and ensure trials are equipped and compliant:

  • Clinical Trial Material Manufacturing
  • Regulatory and Quality Compliance Expertise
  • Stability Programs for CTMs
  • Streamlined Production and Packaging
  • Blinding Processes
  • Comparator Drug Sourcing
  • Ancillary Supply Management

Clinical Trial Material (CTM) Manufacturing

Benuvia offers GMP-compliant production of trial materials, including psilocybin and dronabinol, with scalable options for clinical studies. Our facilities are equipped to handle precise batch sizes, ensuring reliable, high-quality materials for every trial phase.

Benuvia has been a game-changer for our trial readiness. Their seamless integration of comparator sourcing, ancillary supply management, and blinding processes ensured our clinical materials were delivered on time and met the highest regulatory standards. The team’s expertise and proactive approach kept our trial on schedule and gave us confidence every step of the way.

Global Biopharma Company

Clinical Operations Director

Speak with an Expert

Muthiah Chinnasamy, Ph.D.

Vice President of API and Formulation R&D

Dr. Muthiah Chinnasamy, Vice President of API and Formulation R&D, has over two decades of experience in pharmaceutical R&D and manufacturing. His expertise spans API process development, regulatory compliance, and managing CDMO operations across the globe.

With leadership roles at organizations like Cambrex and Bachem, Muthiah has developed FDA-approved drugs, optimized manufacturing processes, and prepared over 300 business proposals. A Ph.D. in synthetic organic chemistry with international postdoctoral experience, he brings a global perspective to solving complex challenges.

Muthiah is passionate about advancing pharmaceutical innovation and is eager to share his insights, answer your questions, and discuss how Benuvia can support your API and formulation development needs.

Contact Me

"*" indicates required fields